Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways

about

Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways

Item

http://www.wikidata.org/entity/Q59138098

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@en

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@nl

type

Item

label

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@en

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@nl

prefLabel

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@en

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@nl

P1476

Verapamil Ameliorates Hepatic ...... racting Protein/NLRP3 Pathways

@en

P2093

Feng Zhou

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Yancheng Xu

http://www.w3.org/2001/XMLSchema#string

Yimeng Hu

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The inflammasomes

Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation

Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.

Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.

Inflammasome is a central player in the induction of obesity and insulin resistance.

P304

640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2018.00640

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30429827

http://www.w3.org/2001/XMLSchema#string

P932

6220071

http://www.w3.org/2001/XMLSchema#string